Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 3Thoracic 1Other 1Breast 1

Conditions

Breast Neoplasms 279Triple Negative Breast Neoplasms 146Neoplasm Metastasis 27Ovarian Neoplasms 23Carcinoma, Non-Small-Cell Lung 17Inflammatory Breast Neoplasms 15Pancreatic Neoplasms 12Neoplasms 11Endometrial Neoplasms 11Breast Neoplasms, Male 11Colorectal Neoplasms 8Carcinoma, Ductal, Breast 8Stomach Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Lung Neoplasms 7Prostatic Neoplasms 6Melanoma 6Fallopian Tube Neoplasms 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pathologic Complete Response 5HER2-positive Breast Cancer 5Carcinoma, Ovarian Epithelial 5Esophageal Neoplasms 4Carcinoma, Lobular 4Urinary Bladder Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Multiple Myeloma 3

Interventions

eribulin 1Trastuzumab 1Paclitaxel 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Ginkgo Extract 1Fluorodeoxyglucose F18 1Exercise Therapy 1Doxorubicin 1Docetaxel 1Cycloserine 1Cyclophosphamide 1Carnitine 1Carboplatin 1Aromatase Inhibitors 1Amifostine 1Acupuncture Therapy 12,2'-dithiodiethanesulfonic acid 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Carboplatin × Breast × Clear all
NCT00755313 2017-11-24

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

University of California, San Francisco

Completed
81 enrolled
Breast

Breast Neoplasms, Fatigue, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡